rizatriptan benzoate

Macleods Pharmaceuticals Limited🇺🇸 United States

FDA Page

Effective Date: Feb 27, 2023
Approval ID: 57ed2505-28f1-4292-b3c3-a49bf0f7c683
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RIZATRIPTAN BENZOATE orally disintegrating tablets safely and effectively. See full prescribing information for RIZATRIPTAN BENZOATE orally disintegrating tablets. RIZATRIPTAN BENZOATE Orally Disintegrating Tablets, for oral use Initial U.S. Approval: 1998

Quick Stats

Total Products2

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.